[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340877-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340877-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","prognostic-biomarker-dars2-correlated-with-immune-infiltrates-in-bladder-tumor-original-research","Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor - Original Research","","DARS2 is identified as a pivotal aminoacyl-tRNA synthetase member, yet its biological role in bladder cancer has remained unclear. Using TCGA data, the study evaluates relationships between DARS2 expression, patient prognosis, tumor stage, and immune infiltration patterns. Clinical sample validation and complementary cell and animal experiments further test DARS2’s functional impact on proliferation, metastasis, tumorigenesis, immune escape, and PD-L1 regulation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prognostic-biomarker-dars2-correlated-with-immune-infiltrates-in-bladder-tumor-original-research/340877/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prognostic-biomarker-dars2-correlated-with-immune-infiltrates-in-bladder-tumor-original-research/340877.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the study on DARS2 in bladder cancer?","Question",{"text":63,"@type":64},"To determine whether DARS2 expression correlates with prognosis, tumor stage, and immune infiltration, and to explore its biological functions and therapeutic relevance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which dataset and validation approach were used to link DARS2 with outcomes?",{"text":68,"@type":64},"The Cancer Genome Atlas (TCGA) database was used for correlation analyses, and clinical samples from The First Afﬁliated Hospital of Nanchang University were used to validate findings.",{"name":70,"@type":61,"acceptedAnswer":71},"How does DARS2 relate to immune evasion in bladder tumor?",{"text":72,"@type":64},"Immune infiltration analysis suggests DARS2 may facilitate immune evasion by modulating PD-L1, and experiments support involvement in immune escape and PD-L1 levels.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340877,1790189369,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","TYPE Original Research PUBLISHED 17 January 2024  \nDOI 10.3389/fimmu.2023.1301945  \nOPEN ACCESS  \nEDITED BY  \nTakaji Matsutani, Maruho, Japan  \nREVIEWED BY Liang-min Fu,  \nThe First Afﬁliated Hospital of Sun Yat-sen University, China  \nShahid Banday,  \nUniversity of Massachusetts Medical School, United States  \n*CORRESPONDENCE Bin Fu  \n [urofbin@163.com](urofbin@163.com)[ ](urofbin@163.com)Jianqiang Nie  \n[jianqiang1614@163.com](jianqiang1614@163.com)[ ](jianqiang1614@163.com)Xiaoqiang Liu  \n [shaw177@163.com](shaw177@163.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 25 September 2023  \nACCEPTED 07 December 2023  \nPUBLISHED 17 January 2024  \nCITATION  \nYang H, Ma L, Deng W, Fu B, Nie J and Liu X (2024) Prognostic biomarker DARS2 correlated with immune inﬁltrates in bladder tumor.  \nFront. Immunol. 14:1301945 .  \ndoi: 10.3389/fimmu.2023.1301945  \nCOPYRIGHT  \n© 2024 Yang, Ma, Deng, Fu, Nie and Liu. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nPrognostic biomarker DARS2 correlated with immune inﬁltrates in bladder tumor  \nHailang Yang 1†, Li Ma 2†, Wen Deng 1,3, Bin Fu 1,3*, Jianqiang Nie 1* and Xiaoqiang Liu 1,3*  \n1 Department of Urology, The First Afﬁliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China, 2 Department of Pathology, The First Afﬁliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China, 3Jiangxi Institute of Urology, Nanchang, China  \nBackground: DARS2 is a pivotal member of the Aminoacyl-tRNA synthetases family that is critical for regulating protein translation . However, the biological role of DARS2 in bladder cancer remains elusive.  \nMethods: We analyzed the correlation between DARS2 expression and prognosis, tumor stage, and immune inﬁltration in bladder cancer using The Cancer Genome Atlas (TCGA) database. We validated ﬁndings in clinical samples from The First Afﬁliated Hospital of Nanchang University and explored the biological functions of DARS2 using cell and animal models.  \nResults: We found DARS2 to be upregulated in bladder cancer, associated with tumor progression and poor prognosis. Immune inﬁltration analysis suggested that DARS2 may facilitate immune evasion by modulating PD-L1 . Cell and animal experiments validated that DARS2 knockdown andoverexpress can inhibit or increase cancer cell proliferation, metastasis, tumorigenesis, immune escape, and PD-L1 levels.  \nConclusions: Our study reveals DARS2 as a potential prognostic biomarker and immunotherapy target in BLCA.  \nKEYWORDS  \nDARS2, bladder cancer, prognosis, immune inﬁltration, PD-L1  \n1 Introduction  \nBladder cancer (BLCA) is the most common malignancy of the urinary tract and one of the most prevalent cancers worldwide (1) . Globally, it is the ninth most prevalent cancer, and among males, it ranks sixth most common (2) . Approximately 70-80% of patients are diagnosed with non-muscle-invasive BLCA at the initial diagnosis. However, up to 20% of patients progress to advanced, high-grade muscle-invasive BLCA, with a 5-year survival rate of less than 50%(3) . Despite signiﬁcant advancementsin the treatment of BLCA, including targeted therapies and immunotherapy, the survival rates for BLCA have not shown signiﬁcant improvement over the past three  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \ndecades (4, 5) . Therefore, investigating the underlying mechanisms of BLCA development and identifying novel therapeutic targets is of paramount importance for improving patient prognosis.  \naminoacyl-tRNA synthetases (ARS) are critical ","cbCaivtctEooGOlX","https://ap.wps.com/l/cbCaivtctEooGOlX","pdf",7367080,11,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Key words","[{\"question\":\"What is the main purpose of the study on DARS2 in bladder cancer?\",\"answer\":\"To determine whether DARS2 expression correlates with prognosis, tumor stage, and immune infiltration, and to explore its biological functions and therapeutic relevance.\"},{\"question\":\"Which dataset and validation approach were used to link DARS2 with outcomes?\",\"answer\":\"The Cancer Genome Atlas (TCGA) database was used for correlation analyses, and clinical samples from The First Afﬁliated Hospital of Nanchang University were used to validate findings.\"},{\"question\":\"How does DARS2 relate to immune evasion in bladder tumor?\",\"answer\":\"Immune infiltration analysis suggests DARS2 may facilitate immune evasion by modulating PD-L1, and experiments support involvement in immune escape and PD-L1 levels.\"}]","Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor - Original Research | PDF",1790039291,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/335b7bda87d48f0ff8c1fe09650c9b28.webp",983,1389,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/959493a62ca9dbe1cd9b848075234d4a.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96255fa11c9daf109759b120009ae9e2.webp",981,1386,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f95df913663da09567e9b090b7ccf28.webp",980,1385]